首页 正文

Azithromycin Reduces Markers of Vascular Damage in Pediatric Patients With Sickle Cell Disease

{{output}}
Background: Immunomodulatory effects of macrolides in chronic inflammation are well known. In this study, we tested our hypothesis that azithromycin (AZT) can decrease inflammation in pediatric patients with sickle cell disease (... ...